Kidney Week 2025 Early Program - Care of Kidney Transplant Candidates and Recipients-Moderated Discussion

Video Transcription

Video Summary

The transcript captures a moderated conference discussion on kidney transplant evaluation, focusing on tradeoffs between living and deceased donor transplantation and the burdens of pre-transplant testing. Panelists debate whether high living-donor volume affects deceased-donor practices and note that policy changes (e.g., pediatric allocation) can reduce living donation. They discuss diagnosing “diabetic nephropathy” without biopsy, emphasizing missed non-diabetic kidney diseases and when genetic testing (e.g., APOL1) might matter for recipients or related donors, while cautioning that interpretation and consequences are uncertain.<br /><br />A major theme is cardiac risk screening: centers often require stress tests and even catheterization due to regulatory pressure over one-year outcomes and surgeon concerns, despite unclear evidence that aggressive testing prevents perioperative events. The role of pathology and AI is discussed in diagnosing native disease, interpreting post-transplant findings, and potentially improving donor-organ biopsy assessment. Audience questions address catheterization in pre-emptive patients, routine GN serologies in ESRD, and how to define “asymptomatic” in sedentary patients.

Asset Subtitle

Roy D. Bloom, Samira S. Farouk, Edmund Huang, Syed Ali Husain, Vineeta Kumar, Dana V. Rizk, Karin A. True

Meta Tag

Module TRX

Speaker FACULTY FACULTY

Keywords

kidney transplant evaluation

living donor vs deceased donor transplantation

pre-transplant cardiac risk screening

stress testing and cardiac catheterization

diabetic nephropathy misdiagnosis and non-diabetic kidney disease

genetic testing in transplantation (APOL1)